SERONEGATIVE MYASTHENIA-GRAVIS - A PLASMA FACTOR INHIBITING AGONIST-INDUCED ACETYLCHOLINE-RECEPTOR FUNCTION COPURIFIES WITH IGM

被引:62
作者
YAMAMOTO, T [1 ]
VINCENT, A [1 ]
CIULLA, TA [1 ]
LANG, B [1 ]
JOHNSTON, I [1 ]
NEWSOMDAVIS, J [1 ]
机构
[1] JOHN RADCLIFFE HOSP,INST MOLEC MED,NEUROSCI GRP,OXFORD OX3 9DU,ENGLAND
关键词
D O I
10.1002/ana.410300407
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Anti-acetylcholine receptor antibodies cannot be detected by standard radioimmunoassay in 10 to 15% of patients with generalized myasthenia gravis (seronegative myasthenia gravis). We investigated the effect of seronegative myasthenia gravis plasma on Na-22+ flux through acetylcholine receptors and voltage-gated sodium channels in the human rhabdomyosarcoma cell line, TE671. Fourteen of 19 seronegative MG plasmas inhibited acetylcholine receptor Na-22+ flux; none inhibited voltage-gated sodium channel flux. The inhibitory activity was found in the IgG-depleted fraction, and copurified with IgM after gel-filtration chromatography. Inhibitory activity was absent from the plasma of 8 healthy control subjects and of 6 patients with the Lambert-Eaton myasthenic syndrome, but was present in the IgG-depleted plasma fraction of 4 of 6 seropositive patients with myasthenia gravis and all 5 patients with demyelinating polyneuropathy. We conclude that a low-affinity serum factor, probably an IgM antibody, found in a high proportion in patients with seronegative and those with seropositive myasthenia gravis may contribute to the muscle weakness in myasthenia gravis, but its role in these and other neuroimmunological disorders requires further investigation.
引用
收藏
页码:550 / 557
页数:8
相关论文
共 27 条
[1]  
CATTERALL WA, 1977, J BIOL CHEM, V252, P8669
[2]  
DRACHMAN DB, 1987, ANN NY ACAD SCI, V505, P1
[3]   CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[4]   PLASMA FROM MYASTHENIA-GRAVIS PATIENTS REDUCES ACETYLCHOLINE-RECEPTOR AGONIST-INDUCED NA+ FLUX INTO TE671 CELL-LINE [J].
LANG, B ;
RICHARDSON, G ;
REES, J ;
VINCENT, A ;
NEWSOMDAVIS, J .
JOURNAL OF NEUROIMMUNOLOGY, 1988, 19 (1-2) :141-148
[5]   DETERMINATION OF ACETYLCHOLINE-RECEPTOR ANTIBODY IN MYASTHENIA-GRAVIS - CLINICAL USEFULNESS AND PATHOGENETIC IMPLICATIONS [J].
LEFVERT, AK ;
BERGSTROM, K ;
MATELL, G ;
OSTERMAN, PO ;
PIRSKANEN, R .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1978, 41 (05) :394-403
[6]   EXPERIMENTAL AUTOIMMUNE MYASTHENIA-GRAVIS - CELLULAR AND HUMORAL IMMUNE-RESPONSES [J].
LENNON, VA ;
LINDSTROM, JM ;
SEYBOLD, ME .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1976, 274 (MAY28) :283-299
[7]   ANTIBODY TO ACETYLCHOLINE-RECEPTOR IN MYASTHENIA-GRAVIS - PREVALENCE, CLINICAL CORRELATES, AND DIAGNOSTIC VALUE [J].
LINDSTROM, JM ;
SEYBOLD, ME ;
LENNON, VA ;
WHITTINGHAM, S ;
DUANE, DD .
NEUROLOGY, 1976, 26 (11) :1054-1059
[8]  
LUTHER MA, 1989, J NEUROSCI, V9, P1082
[9]   DIAPHRAGMATIC MYASTHENIA IN MOTHER AND CHILD [J].
MIER, AK ;
HAVARD, CWH .
POSTGRADUATE MEDICAL JOURNAL, 1985, 61 (718) :725-727
[10]  
MOSSMAN S, 1986, LANCET, V1, P116